B.C. MEDICAL INSTRUMENTS ApS

Q: What is the CVR number of B.C. MEDICAL INSTRUMENTS ApS?

B.C. MEDICAL INSTRUMENTS ApS is registered with CVR / Virk under CVR 85339028.

Q: How many employees does B.C. MEDICAL INSTRUMENTS ApS have?

B.C. MEDICAL INSTRUMENTS ApS employs 1 people as of the latest annual report.

Q: Where is B.C. MEDICAL INSTRUMENTS ApS headquartered?

B.C. MEDICAL INSTRUMENTS ApS's registered address is Vesterbro 68.

APSBankrupt

CVR 85339028Vesterbro 68, 4500 Nykøbing SjWholesale of pharmaceutical and medical goods· NACE 4646Est. 1978 · 47 years old1 employees

Overview

B.C. MEDICAL INSTRUMENTS ApS is a Danish APS based in Nykøbing Sj, operating in the Wholesale of pharmaceutical and medical goods sector. Incorporated in 1978, the company has 1 employee and reported a gross profit of -DKK 26.1k in its latest annual filing.

Gross profit 2024

-26.1K DKK

−225% vs 2023

EBITDA margin (of gross profit)

117.4 %

−12% vs 2023

Net profit 2024

-32K DKK

-14% vs 2023

Key ratios

See full ratios →

19.2 %

Weak

Among the 40% lowest rated companies in the industry

20202024

1.2×

Weak

Among the 40% lowest rated companies in the industry

20202024

-11.1 %

Weak

Among the 30% lowest rated companies in the industry

20202024

EBITDA — year on year

DKK thousands

Key figures

Annual report 2024

Gross profit	-26.1K DKK	-225%
EBITDA	-30.7K DKK	-12%
Net profit	-32K DKK	-14%
Total assets	287.3K DKK	-10%
Equity	55.1K DKK	-37%
Employees	1	—

Financial development

In its most recent annual report (2024), B.C. MEDICAL INSTRUMENTS ApS reported a gross profit of -DKK 26.1k, a decrease of 225% on the year before. The figures on this page draw on 5 annual filings covering 2020 to 2024. The bottom line showed a net loss of DKK 32.0k.

At the end of 2024, equity financed 19.2% of the balance sheet, and current assets covered short-term debt 1.2 times.

Financials

Gross profit

DKK thousands

EBITDA

DKK thousands

Income statement

DKK thousands

Item	2024	2023	2022	2021	2020
Gross profit	-26	21	42	126	190
Staff expenses	-5	-48	-47	-103	-125
EBITDA	-31	-27	-5	23	66
Depreciation & amort.	-0	-0	-0	-0	-0
EBIT	-31	-27	-5	23	66
Net financials	-7	-5	-7	-3	-2
Profit before tax	-38	-32	-12	20	64
Tax	-6	-4	-0	7	15
Net profit	-32	-28	-12	13	49

Get a credit rating – not just the numbers

Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.

See the credit rating

Balance sheet

DKK thousands

Item	2024	2023	2022	2021	2020
Total assets	287	321	339	396	312
Equity	55	87	115	167	209
Long-term debt	0	0	0	0	0
Short-term debt	232	234	224	229	103
Total debt	232	234	224	229	103

Financial ratios

5-year trend

EBITDA margin (of gross profit)

<−999 %

20202024

Equity ratio

19.2 %

Weak

Among the 40% lowest rated companies in the industry

20202024

Return on equity

-58.1 %

Very weak

Among the 10% lowest rated companies in the industry

20202024

Net profit margin (of gross profit)

<−999 %

20202024

Asset turnover (of gross profit)

-0.09×

20202024

Debt / equity

4.22×

Very weak

Among the 20% lowest rated companies in the industry

20202024

Sector performance

23 of 28 ratios graded

28 financial ratios from the latest filing, each graded against companies in the same industry.

Profitability

Return on equity (ROE)Very weak

Among the 10% lowest rated companies in the industry

Net profit as a percentage of equity — the return the owners earned on their invested capital this year.

Return on assets (ROA)Weak

Among the 30% lowest rated companies in the industry

Net profit as a percentage of total assets — the return generated on the capital employed.

Return on net assets (RONA)Very weak

Among the 10% lowest rated companies in the industry

Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.

Basic earning power (BEP)Weak

Among the 30% lowest rated companies in the industry

EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.

Capacity ratioVery weak

Among the 10% lowest rated companies in the industry

Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.

Gross marginNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.

Operating marginNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.

Net profit marginNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

The profit for the year as a share of revenue — the company's ability to turn revenue into profit.

Liquidity

Current ratioWeak

Among the 40% lowest rated companies in the industry

Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.

Quick ratioWeak

Among the 30% lowest rated companies in the industry

Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.

Cash ratioWeak

Among the 30% lowest rated companies in the industry

Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.

Current assets to equityVery weak

Among the 20% lowest rated companies in the industry

Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.

Fixed assets to long-term capitalVery strong

Among the 10% highest rated companies in the industry

Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.

Cash conversion ratioWeak

Among the 30% lowest rated companies in the industry

Cash flow relative to profit — the ability to convert reported profits into accessible cash.

Debt & solvency

Solidity ratioWeak

Among the 40% lowest rated companies in the industry

Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.

Debt ratioWeak

Among the 40% lowest rated companies in the industry

Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.

Debt to equityVery weak

Among the 20% lowest rated companies in the industry

Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.

Liabilities to equityVery weak

Among the 20% lowest rated companies in the industry

Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.

Income to debtWeak

Among the 30% lowest rated companies in the industry

Profit relative to debt — the ability to create earnings while operating with debt.

EBITDA to debtWeak

Among the 30% lowest rated companies in the industry

EBITDA relative to debt — how much operating earnings are available to service the debt.

Interest coverageWeak

Among the 30% lowest rated companies in the industry

The ability to pay the interest on the company's debt out of its earnings.

Interest rate on debtVery weak

Among the 20% lowest rated companies in the industry

Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.

Interest marginVery weak

Among the 20% lowest rated companies in the industry

The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.

Efficiency & development

Equity to contributed capitalWeak

Among the 30% lowest rated companies in the industry

Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.

One-year change in equityVery weak

Among the 20% lowest rated companies in the industry

The size of this year's increase or decrease in the company's equity.

One-year change in debtAverage

Around the average of companies in the same industry

The size of this year's increase or decrease in the company's debt.

Asset turnoverNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Revenue relative to total assets — the ability to generate revenue from the asset base.

Inventory turnoverNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.

Annual reports & filings

Annual report 2024
Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
View PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
View PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
View PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
View PDF
Annual report 2020
Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
View PDF

People & ownership

Management

Actively employed in the business

Name	Role	Member since

Former (5)


JS Jens Steen Dirch Poulsen Management	Management	2020 – 2021
OA Ove Anders Brandgaard Audit	Audit	1978 – 1991
AD Asger Dirch Poulsen Management	Management	1978 – 2019
FM Finn Machenhauer Liquidator	Liquidator	2025 – 2026
LD Lizette Dirch Gehlsen Management	Management	2021 – 2025

Board of directors

Non-executive oversight

Name	Role	Member since

Former (3)


JS Jens Steen Dirch Poulsen Board of Directors	Board of Directors	1978 – 1997
GA Garth Asbjørn Eisvang Board of Directors	Board of Directors	1978 – 1997
AD Asger Dirch Poulsen Board of Directors	Board of Directors	1978 – 1997

Shareholders

Active legal owners

Shareholder	Type	Ownership	Votes	Registered
Jens Steen Dirch Poulsen	Individual	50–66.65%	50–66.65%	1978
Asger Dirch Poulsen	Individual	100%	100%	2019

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.

One in three Danish companies experiences fraud

Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.

See the fraud module

Related companies

Company hierarchy

No registered parent or subsidiaries

Board network connections

Board members of B.C. MEDICAL INSTRUMENTS ApS also hold positions in 20 other companies.

Person	Role here	Other companies
Finn Machenhauer	Liquidator	16 companiesMany roles
Asger Dirch Poulsen	Management	2 companies
Garth Asbjørn Eisvang	Board of Directors	2 companies

Frequently asked questions

What is the CVR number of B.C. MEDICAL INSTRUMENTS ApS?

B.C. MEDICAL INSTRUMENTS ApS is registered with CVR / Virk under CVR 85339028.

What is the gross profit of B.C. MEDICAL INSTRUMENTS ApS?

B.C. MEDICAL INSTRUMENTS ApS reported a gross profit of -DKK 26.1k in 2024.

How many employees does B.C. MEDICAL INSTRUMENTS ApS have?

B.C. MEDICAL INSTRUMENTS ApS employs 1 people as of the latest annual report.

Where is B.C. MEDICAL INSTRUMENTS ApS headquartered?

B.C. MEDICAL INSTRUMENTS ApS's registered address is Vesterbro 68.